Low Endotoxin Recovery: A Mitigation Approach Case Study
This white paper discusses the Low Endotoxin Recovery (LER) phenomenon in the drug testing and mitigation approach using the ENDO-RS® kit and ENDOLISA® assay for detecting endotoxin interference. Authors Dr Christian Faderl and Kevin L. Williams detail the steps for conducting a demasking study and walk through the process, providing a comprehensive case study.
"Once a development scheme has been achieved, the user can test this using different lots of materials (drug and test kits and reagents) and, if desired, using different analysts. Such a test, once developed, with validation performed and documented, should be no more difficult to perform routinely than any other QC bacterial endotoxin test (BET)," the authors state.
Start Combating Masked Endotoxin
Don’t miss this opportunity to stay ahead in endotoxin detection. Complete the form below to access the white paper, which will be sent directly to your email after submission. By providing your information, you agree to receive additional emails from bioMérieux about endotoxin testing.
To find out more about the management of your personal data and to exercise your rights, see our privacy policy.